Pedrique B, Strub-Wourgaft N, Some C, Olliaro PL, Trouiller P, et al.
2013-12-01 • Lancet Global Health
2013-12-01 • Lancet Global Health
In 1975-99, only 1·1% of new therapeutic products had been developed for neglected diseases. Since then, several public and private initiatives have attempted to mitigate this imbalance....
Drugs offer a simple, cost-effective solution to many health problems, provided they are available, affordable, and properly used. However, effective treatment is lacking in poor countri...
Trouiller P, Olliaro PL, Torreele E, Orbinski J, Laing R, et al.
2002-06-22 • Lancet
2002-06-22 • Lancet
There is a lack of effective, safe, and affordable pharmaceuticals to control infectious diseases that cause high mortality and morbidity among poor people in the developing world. We an...
